Charles River Laboratories International (CRL) Competitors $106.41 +6.66 (+6.68%) As of 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRL vs. MTD, WAT, ILMN, TECH, BIO, BRKR, PACB, HBIO, TMO, and AShould you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Charles River Laboratories International vs. Mettler-Toledo International Waters Illumina Bio-Techne Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Charles River Laboratories International (NYSE:CRL) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, community ranking, valuation, risk, analyst recommendations, media sentiment, earnings and profitability. Does the media favor CRL or MTD? In the previous week, Charles River Laboratories International had 14 more articles in the media than Mettler-Toledo International. MarketBeat recorded 37 mentions for Charles River Laboratories International and 23 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.28 beat Charles River Laboratories International's score of 0.80 indicating that Mettler-Toledo International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Charles River Laboratories International 18 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 17 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of CRL or MTD? 98.9% of Charles River Laboratories International shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 1.3% of Charles River Laboratories International shares are owned by insiders. Comparatively, 1.9% of Mettler-Toledo International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is CRL or MTD more profitable? Mettler-Toledo International has a net margin of 22.29% compared to Charles River Laboratories International's net margin of 0.52%. Charles River Laboratories International's return on equity of 14.69% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Charles River Laboratories International0.52% 14.69% 6.79% Mettler-Toledo International 22.29%-591.54%26.78% Which has more volatility & risk, CRL or MTD? Charles River Laboratories International has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.28, meaning that its share price is 28% more volatile than the S&P 500. Do analysts prefer CRL or MTD? Charles River Laboratories International currently has a consensus target price of $182.00, suggesting a potential upside of 72.28%. Mettler-Toledo International has a consensus target price of $1,380.50, suggesting a potential upside of 28.19%. Given Charles River Laboratories International's higher probable upside, research analysts clearly believe Charles River Laboratories International is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Charles River Laboratories International 1 Sell rating(s) 15 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.94Mettler-Toledo International 1 Sell rating(s) 5 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.22 Does the MarketBeat Community believe in CRL or MTD? Charles River Laboratories International received 121 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 59.47% of users gave Charles River Laboratories International an outperform vote while only 56.62% of users gave Mettler-Toledo International an outperform vote. CompanyUnderperformOutperformCharles River Laboratories InternationalOutperform Votes49359.47% Underperform Votes33640.53% Mettler-Toledo InternationalOutperform Votes37256.62% Underperform Votes28543.38% Which has preferable earnings and valuation, CRL or MTD? Mettler-Toledo International has lower revenue, but higher earnings than Charles River Laboratories International. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Charles River Laboratories International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCharles River Laboratories International$4.05B1.28$474.62M$0.15704.27Mettler-Toledo International$3.87B5.80$863.14M$40.5326.57 SummaryCharles River Laboratories International and Mettler-Toledo International tied by winning 9 of the 18 factors compared between the two stocks. Remove Ads Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRL vs. The Competition Export to ExcelMetricCharles River Laboratories InternationalCommercial physical research IndustryMedical SectorNYSE ExchangeMarket Cap$5.19B$3.10B$5.32B$18.47BDividend YieldN/A2.61%5.11%4.25%P/E Ratio704.2782.4421.6330.90Price / Sales1.28118.63372.9226.25Price / Cash7.4834.5738.1517.54Price / Book1.562.306.374.27Net Income$474.62M$118.81M$3.20B$1.02B7 Day Performance-21.14%-1.41%5.06%3.62%1 Month Performance-38.32%-19.53%-7.61%-7.31%1 Year Performance-56.23%-16.12%7.03%-0.58% Charles River Laboratories International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRLCharles River Laboratories International4.7701 of 5 stars$106.41+6.7%$182.00+71.0%-58.7%$5.23B$4.05B709.4021,800Short Interest ↓Analyst RevisionNews CoverageGap UpHigh Trading VolumeMTDMettler-Toledo International4.1281 of 5 stars$1,033.42+1.1%$1,380.50+33.6%-17.4%$21.54B$3.87B25.5018,000News CoveragePositive NewsGap UpHigh Trading VolumeWATWaters4.1177 of 5 stars$325.12+0.1%$401.31+23.4%+0.9%$19.32B$2.96B30.368,200Gap UpHigh Trading VolumeILMNIllumina4.5357 of 5 stars$73.45-1.0%$140.65+91.5%-41.2%$11.63B$4.37B-9.569,030High Trading VolumeTECHBio-Techne4.9002 of 5 stars$52.31+1.1%$81.25+55.3%-24.0%$8.27B$1.20B52.843,100Analyst RevisionPositive NewsGap DownHigh Trading VolumeBIOBio-Rad Laboratories4.6566 of 5 stars$229.42+1.7%$395.20+72.3%-18.3%$6.43B$2.57B-3.538,200Short Interest ↓Positive NewsGap UpBRKRBruker4.6111 of 5 stars$38.70+6.1%$68.00+75.7%-55.7%$5.87B$3.37B50.928,520Gap UpHigh Trading VolumePACBPacific Biosciences of California2.5713 of 5 stars$1.32+7.3%$2.46+86.2%-57.1%$393.17M$154.01M-0.80730Positive NewsGap DownHBIOHarvard Bioscience3.6293 of 5 stars$0.38-4.9%$4.50+1,082.7%-90.6%$16.77M$94.14M-1.15490Analyst ForecastGap UpTMOThermo Fisher Scientific4.9347 of 5 stars$437.800.0%$653.23+49.2%-22.5%$165.16B$42.88B26.49130,000Positive NewsGap UpHigh Trading VolumeAAgilent Technologies4.6612 of 5 stars$103.48+0.5%$150.83+45.8%-27.1%$29.50B$6.51B23.7917,900Positive NewsGap Up Remove Ads Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CRL) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersThe biggest story CNBC isn't talking about (yet)This Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredDeFi Coin on Verge of Breakout!Crypto’s down — but the fundamentals aren’t. Strategic investors are using this dip to scoop up undervalued...Crypto 101 Media | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.